Oura's $2.2 billion IPO mainly rewards existing shareholders, especially Forerunner Ventures

Forerunner Ventures will sell its entire stake in Finnish health‑tech company Oura for as much as $1.26 billion as part of Oura’s $2.2 billion initial public offering that is set to debut on the New York Stock Exchange next month. The move will turn Forerunner’s early bet into a multi‑hundred‑percent return and will make the venture firm one of the biggest sellers in the float.

Oura, best known for its sleek smart ring that tracks sleep, activity and heart‑rate variability, has ridden a wave of consumer interest in personal health data that surged during the COVID‑19 pandemic. The company raised $100 million in a 2021 round that lifted its valuation to $2 billion, and it posted its first profit in 2023 after cutting costs and expanding its subscription base in the United States and Europe. The timing of the IPO coincides with a broader market appetite for wellness‑tech firms, as investors look for growth stories that can survive a tightening monetary environment.

Forerunner, which invested in Oura in 2019 when the ring was still a niche product, bought the stake for roughly $100 million. The planned sale at $1.26 billion represents a more than 12‑times return on capital, dwarfing the proceeds that Oura will raise from new investors, estimated at $350 million. Other early backers, including Andreessen Horowitz and the co‑founder of Spotify, are also slated to sell portions of their holdings, meaning most of the IPO proceeds will go to existing shareholders rather than the company’s balance sheet. Analysts note that the heavy sell‑side pressure could keep the opening price modest, but they also expect the float to give Oura a public market platform to fund product upgrades and expand its health‑services ecosystem.

The listing is slated for early October, with the company planning to use the fresh capital to accelerate research into clinical‑grade metrics and to deepen partnerships with insurers and employers. If the shares trade above the $20 range that underwriters have suggested, Oura could still secure enough cash to invest in new hardware generations and AI‑driven insights. The IPO will also serve as a benchmark for other wearable‑tech startups seeking exits, showing that venture firms can reap outsized returns even when the bulk of the money goes to early investors rather than the operating business.